Hoang U, Agrawal U, Ordonez-Mena J, Marcum Z, Radin J, Araujo A
JMIR Res Protoc. 2025; 14:e60669.
PMID: 39841515
PMC: 11799813.
DOI: 10.2196/60669.
Aziz F, Farooqui N, Abbas T, Javaid M, Rafaqat W, Zhamalbekova A
Infect Genet Evol. 2024; 126:105694.
PMID: 39608424
PMC: 11733314.
DOI: 10.1016/j.meegid.2024.105694.
Bergeron H, Tripp R
Viruses. 2022; 14(11).
PMID: 36366494
PMC: 9692685.
DOI: 10.3390/v14112396.
Ostrycharz E, Hukowska-Szematowicz B
Int J Mol Sci. 2022; 23(18).
PMID: 36142450
PMC: 9504570.
DOI: 10.3390/ijms231810536.
Kircher M, Chludzinski E, Krepel J, Saremi B, Beineke A, Jung K
Int J Mol Sci. 2022; 23(5).
PMID: 35269624
PMC: 8910329.
DOI: 10.3390/ijms23052481.
Contribution of Nanotechnologies to Vaccine Development and Drug Delivery against Respiratory Viruses.
Ftouh M, Kalboussi N, Abid N, Sfar S, Mignet N, Bahloul B
PPAR Res. 2021; 2021:6741290.
PMID: 34721558
PMC: 8550859.
DOI: 10.1155/2021/6741290.
Respiratory Syncytial Virus (RSV) G Protein Vaccines With Central Conserved Domain Mutations Induce CX3C-CX3CR1 Blocking Antibodies.
Bergeron H, Murray J, Nunez Castrejon A, DuBois R, Tripp R
Viruses. 2021; 13(2).
PMID: 33672319
PMC: 7926521.
DOI: 10.3390/v13020352.
Chimeric Measles Virus (MV/RSV), Having Ectodomains of Respiratory Syncytial Virus (RSV) F and G Proteins Instead of Measles Envelope Proteins, Induced Protective Antibodies against RSV.
Sawada A, Ito T, Yamaji Y, Nakayama T
Vaccines (Basel). 2021; 9(2).
PMID: 33669275
PMC: 7920054.
DOI: 10.3390/vaccines9020156.
Investigating the Interaction between Negative Strand RNA Viruses and Their Hosts for Enhanced Vaccine Development and Production.
Mara K, Dai M, Brice A, Alexander M, Tribolet L, Layton D
Vaccines (Basel). 2021; 9(1).
PMID: 33477334
PMC: 7830660.
DOI: 10.3390/vaccines9010059.
Toll-like receptor 4-mediated respiratory syncytial virus disease and lung transcriptomics in differentially susceptible inbred mouse strains.
Marzec J, Cho H, High M, McCaw Z, Polack F, Kleeberger S
Physiol Genomics. 2019; 51(12):630-643.
PMID: 31736414
PMC: 6962593.
DOI: 10.1152/physiolgenomics.00101.2019.
PD-1 of Sigmodon hispidus: Gene identification, characterization and preliminary evaluation of expression in inactivated RSV vaccine-induced enhanced respiratory disease.
Muralidharan A, Larocque L, Russell M, Creskey M, Li C, Chen W
Sci Rep. 2019; 9(1):11638.
PMID: 31406266
PMC: 6690999.
DOI: 10.1038/s41598-019-48225-x.
Virus genes and host correlates of pathology are markedly reduced during respiratory syncytial and influenza virus co-infection in BALB/c mice.
Ayegbusi O, Ajagbe O, Afowowe T, Aransi A, Olusola B, Awogbindin I
Heliyon. 2019; 5(1):e01094.
PMID: 30623128
PMC: 6319304.
DOI: 10.1016/j.heliyon.2018.e01094.
Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses.
Pickens J, Tripp R
Viruses. 2018; 10(1).
PMID: 29361733
PMC: 5795461.
DOI: 10.3390/v10010048.
Low birth weight contributed to increased serum IL-6 levels in infantile respiratory syncytial virus infection.
Sheng Y, Xu S, Li X, Liu J, Wu X, Xu X
BMC Pediatr. 2017; 17(1):205.
PMID: 29246125
PMC: 5732452.
DOI: 10.1186/s12887-017-0961-2.
Peripheral blood microRNAs expression is associated with infant respiratory syncytial virus infection.
Wang S, Liu P, Yang P, Zheng J, Zhao D
Oncotarget. 2017; 8(57):96627-96635.
PMID: 29228557
PMC: 5722509.
DOI: 10.18632/oncotarget.19364.
Distinct patterns of innate immune activation by clinical isolates of respiratory syncytial virus.
Levitz R, Gao Y, Dozmorov I, Song R, Wakeland E, Kahn J
PLoS One. 2017; 12(9):e0184318.
PMID: 28877226
PMC: 5587315.
DOI: 10.1371/journal.pone.0184318.
Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.
Gonzalez A, Lay M, Jara E, Espinoza J, Gomez R, Soto J
Virulence. 2016; 8(6):685-704.
PMID: 27911218
PMC: 5626346.
DOI: 10.1080/21505594.2016.1265725.
In Hot Pursuit of the First Vaccine Against Respiratory Syncytial Virus.
Kim J, Chang J
Yonsei Med J. 2016; 57(4):809-16.
PMID: 27189271
PMC: 4951454.
DOI: 10.3349/ymj.2016.57.4.809.
The role of Th17 and Treg responses in the pathogenesis of RSV infection.
Mangodt T, Van Herck M, Nullens S, Ramet J, De Dooy J, Jorens P
Pediatr Res. 2015; 78(5):483-91.
PMID: 26267154
DOI: 10.1038/pr.2015.143.
Human respiratory syncytial virus non-structural protein NS1 modifies miR-24 expression via transforming growth factor-β.
Bakre A, Wu W, Hiscox J, Spann K, Teng M, Tripp R
J Gen Virol. 2015; 96(11):3179-3191.
PMID: 26253191
PMC: 4806578.
DOI: 10.1099/jgv.0.000261.